The combination was effective in downregulating the expression of various oncogenic gene products involved in HNSCC growth, survival, invasion, and metastasis along with reduced markers of the proliferation index (Ki-67) and microvessel density (CD31). This evidence concerns the gene PECAM1 and head and neck squamous cell carcinoma.